Microba Life Earnings Estimate

MAP Stock   0.19  0.01  5.56%   
By analyzing Microba Life's earnings estimates, investors can diagnose different trends across Microba Life's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Microba Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Microba Life is projected to generate -0.008 in earnings per share on the 30th of June 2025. Microba Life earnings estimates show analyst consensus about projected Microba Life Sciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Microba Life's historical volatility. Many public companies, such as Microba Life, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Microba Life's earnings estimates, investors can diagnose different trends across Microba Life's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about (8.2 M) in 2024
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Microba Life Earnings per Share Projection vs Actual

About Microba Life Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Microba Life earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Microba Life estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Microba Life fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-63.8 M-60.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microba Stock Analysis

When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.